Search Results - "SUGAWARA, Mitsuru"

Refine Results
  1. 1
  2. 2

    Development of Quantum Dot Lasers for Data-Com and Silicon Photonics Applications by Nishi, Kenichi, Takemasa, Keizo, Sugawara, Mitsuru, Arakawa, Yasuhiko

    “…The device characteristics of semiconductor lasers have been improved with progress in active layer structures. Carrier confinement dimension plays an…”
    Get full text
    Journal Article
  3. 3

    A New Algorithm Optimized for Initial Dose Settings of Vancomycin Using Machine Learning by Imai, Shungo, Takekuma, Yoh, Miyai, Takayuki, Sugawara, Mitsuru

    Published in Biological & pharmaceutical bulletin (01-01-2020)
    “…This study aimed to construct an optimal algorithm for initial dose settings of vancomycin (VCM) using machine learning (ML) with decision tree (DT) analysis…”
    Get full text
    Journal Article
  4. 4

    Impact of renal impairment on early development of severe neutropenia with trifluridine/tipiracil treatment for metastatic colorectal cancer by Saito, Yoshitaka, Takekuma, Yoh, Komatsu, Yoshito, Sugawara, Mitsuru

    Published in Scientific reports (06-11-2024)
    “…Trifluridine/tipiracil (FTD/TPI) with or without bevacizumab is an effective treatment for metastatic colorectal cancer (mCRC). As this agent is mainly…”
    Get full text
    Journal Article
  5. 5

    Impact of preexisting proteinuria on the development of regorafenib-induced problematic proteinuria in real-world metastatic colorectal cancer treatment by Saito, Yoshitaka, Takekuma, Yoh, Komatsu, Yoshito, Sugawara, Mitsuru

    Published in Scientific reports (02-03-2024)
    “…Regorafenib is the first multikinase inhibitor for treating metastatic colorectal cancer (mCRC). Proteinuria is a frequently encountered adverse effect,…”
    Get full text
    Journal Article
  6. 6

    In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid by Sato, Yuki, Itagaki, Shirou, Kurokawa, Toshimitsu, Ogura, Jiro, Kobayashi, Masaki, Hirano, Takeshi, Sugawara, Mitsuru, Iseki, Ken

    Published in International journal of pharmaceutics (17-01-2011)
    “…Dietary polyphenols are thought to be beneficial for human health as antioxidants. Coffee beans contain a common polyphenol, chlorogenic acid. Chlorogenic acid…”
    Get full text
    Journal Article
  7. 7

    Usefulness of the Albumin–Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver Cirrhosis by Nashimoto, Shunsuke, Imai, Shungo, Sugawara, Mitsuru, Takekuma, Yoh

    Published in Biological & pharmaceutical bulletin (01-02-2023)
    “…The Child–Pugh score is widely used to assess liver function and estimate drug clearance in patients with liver cirrhosis. Recently, the albumin–bilirubin…”
    Get full text
    Journal Article
  8. 8

    Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment by Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Sugawara, Mitsuru

    Published in Scientific reports (02-12-2021)
    “…The potential of steroid sparing from day 2 onward is reported in anthracycline-containing regimens for breast cancer treatment. We evaluated whether the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Evaluation of the impact of systemic dexamethasone dosage on docetaxel-induced hand-foot syndrome in patients with breast cancer by Saito, Yoshitaka, Takekuma, Yoh, Takahashi, Masato, Oshino, Tomohiro, Sugawara, Mitsuru

    Published in Scientific reports (18-06-2024)
    “…Hand-foot syndrome (HFS) is a frequently occurring and treatment-requiring adverse effect of docetaxel. We previously reported that systemic dexamethasone…”
    Get full text
    Journal Article
  11. 11

    Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis by Yamaguchi, Atsushi, Saito, Yoshitaka, Okamoto, Keisuke, Narumi, Katsuya, Furugen, Ayako, Takekuma, Yoh, Sugawara, Mitsuru, Kobayashi, Masaki

    Published in Supportive care in cancer (01-12-2021)
    “…Purpose Patients with preexisting autoimmune disease (PAD) are often excluded from clinical trials assessing immune checkpoint inhibitors (ICIs). Therefore,…”
    Get full text
    Journal Article
  12. 12

    Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice by Imai, Shungo, Takekuma, Yoh, Kashiwagi, Hitoshi, Miyai, Takayuki, Kobayashi, Masaki, Iseki, Ken, Sugawara, Mitsuru

    Published in PloS one (29-07-2020)
    “…Artificial neural networks are the main tools for data mining and were inspired by the human brain and nervous system. Studies have demonstrated their…”
    Get full text
    Journal Article
  13. 13

    Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer by Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Oshino, Tomohiro, Sugawara, Mitsuru

    Published in Scientific reports (22-06-2023)
    “…Oral mucositis (OM) is a common adverse effect of docetaxel-containing treatment. This study aimed to assess whether dexamethasone (DEX) dose-dependently…”
    Get full text
    Journal Article
  14. 14

    Anteriorly Tilted Coronal CT of Paranasal Sinuses for Endoscopic Sinus Surgery by Nomura, Kazuhiro, Hemmi, Tomotaka, Sugawara, Mitsuru, Ikeda, Ryoukichi

    “…Conventional coronal CT scans of paranasal sinuses, aligned perpendicularly to the nasal floor, often deviate significantly from the endoscopic view during…”
    Get full text
    Journal Article
  15. 15

    Evaluation of risk factors associated with carboplatin and nab-paclitaxel treatment suspension in patients with non-small cell lung cancer by Saito, Yoshitaka, Takekuma, Yoh, Shinagawa, Naofumi, Sugawara, Mitsuru

    Published in Supportive care in cancer (01-05-2022)
    “…Purpose Carboplatin (CBDCA) + nanoparticle albumin-bound paclitaxel (nab-PTX) is one of the most effective chemotherapeutic regimens for advanced non-small…”
    Get full text
    Journal Article
  16. 16

    Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment by Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Oshino, Tomohiro, Sugawara, Mitsuru

    Published in Scientific reports (22-07-2022)
    “…Oral mucositis (OM) is one of the most common complications associated with chemotherapy. Here, we evaluated whether systemic dexamethasone (DEX) dosage in…”
    Get full text
    Journal Article
  17. 17

    Development of a Method of Liquid Chromatography Coupled with Tandem Mass Spectrometry for Simultaneous Determination of Linezolid and Tedizolid in Human Plasma by Sato, Yuki, Takekuma, Yoh, Daisho, Takayuki, Kashiwagi, Hitoshi, Imai, Shungo, Sugawara, Mitsuru

    Published in Biological & pharmaceutical bulletin (01-04-2022)
    “…It is important to select appropriate antibiotics for infection control. Linezolid and tedizolid are newly developed and synthesized oxazolidinone…”
    Get full text
    Journal Article
  18. 18

    Effect of baseline anemia on the efficacy of docetaxel and ramucirumab for advanced non-small cell lung cancer treatment by Saito, Yoshitaka, Takekuma, Yoh, Sakakibara-Konishi, Jun, Shimizu, Yasushi, Kinoshita, Ichiro, Sugawara, Mitsuru

    Published in BMC cancer (21-10-2024)
    “…Docetaxel (DOC) and ramucirumab (RAM) is one of the most effective regimens for advanced non-small cell lung cancer (NSCLC) treatment. In our previous study,…”
    Get full text
    Journal Article
  19. 19

    Construction of a Risk Prediction Model of Extended Release Oxycodone Tablet-Induced Nausea and Clarification of Predictive Factors by Kumai, Masayoshi, Imai, Shungo, Kato, Shintaro, Koyanagi, Ryo, Tsuruga, Kenkichi, Yamada, Takehiro, Takekuma, Yoh, Sugawara, Mitsuru

    Published in Biological & pharmaceutical bulletin (01-04-2021)
    “…Nausea is a typical adverse event associated with opioids. In this study, we performed logistic regression analysis with the aim of clarifying the risk factors…”
    Get full text
    Journal Article
  20. 20

    Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis by Saito, Yoshitaka, Takekuma, Yoh, Kobayashi, Masaki, Sakamoto, Tatsuhiko, Yamashita, Hiroko, Sugawara, Mitsuru

    Published in Supportive care in cancer (01-12-2021)
    “…Purpose Taxane-associated acute pain syndrome (T-APS) reportedly occurs in approximately 70% of patients undergoing therapy. We have previously reported that…”
    Get full text
    Journal Article